Chuanxue Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chuanxue Ma has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Bin Jiang
Colorectal Surgery Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China
3 shared publications Ao Chen
National Colorectal Disease Center, Nanjing Hospital of Chinese Medicine, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China
2 shared publicationsChungen Zhou
National Colorectal Disease Center, Nanjing Hospital of Chinese Medicine, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China
2 shared publicationsDawei Wang
National Colorectal Disease Center, Nanjing Hospital of Chinese Medicine, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China
2 shared publicationsYafei Lu
The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China
2 shared publications- Yi Liu
Department of Ophthalmology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9716
Rapid FAK Phosphorylation and Progressive Tight-Junction Protein Alterations Under Hyperosmotic Stress in Corneal Epithelial Cells
Dry eye disease (DED) is characterized by tear hyperosmolality and ocular surface injury, but the contribution of focal adhesion kinase (FAK)-related signaling to tight junction (TJ) protein alterations remains unclear. We combined a scopolamine hydrobromide (SCOP)-induced desiccating stress mouse model with human corneal epithelial (HCE-T) cells exposed to NaCl-induced hyperosmolarity, together with transcriptomics, immunofluorescence, immunoblotting, pharmacological inhibition, and siRNA-mediated FAK knockdown. RNA sequencing identified 823 significant large-effect differentially expressed genes; analysis of the 3741 FDR-corrected significant genes revealed significant enrichment of focal adhesion, extracellular matrix–receptor, cell adhesion, and tight junction pathways. In HCE-T cells, hyperosmotic stress increased FAK Tyr397 phosphorylation as early as 1 h without changing total FAK. At 24 h, p-FAK declined while total FAK protein levels remained stable, consistent with dephosphorylation at Tyr397; by 48 h, total FAK protein was lost, accompanied by cell injury. TJ protein abundance and junctional continuity decreased progressively with increasing osmolarity and exposure duration. PF-562271, a dual FAK/Pyk2 inhibitor, produced a concentration-dependent reduction in FAK Tyr397 phosphorylation and, at 2.5 μM, also reduced Pyk2 Tyr402 phosphorylation while partially preserving ZO-1, claudin-1, and occludin abundance. FAK knockdown independently attenuated TJ protein loss and partially preserved ZO-1 junctional continuity under 500 mOsm/L hyperosmotic stress. These findings support a time-dependent contribution of FAK-related signaling to hyperosmotic stress-induced TJ protein remodeling.
- 29 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9716
Open AccessRapid FAK Phosphorylation and Progressive Tight-Junction Protein Alterations Under Hyperosmotic Stress in Corneal Epithelial Cells
Dry eye disease (DED) is characterized by tear hyperosmolality and ocular surface injury, but the contribution of focal adhesion kinase (FAK)-related signaling to tight junction (TJ) protein alterations remains unclear. We combined a scopolamine hydrobromide (SCOP)-induced desiccating stress mouse model with human corneal epithelial (HCE-T) cells exposed to NaCl-induced hyperosmolarity, together with transcriptomics, immunofluorescence, immunoblotting, pharmacological inhibition, and siRNA-mediated FAK knockdown. RNA sequencing identified 823 significant large-effect differentially expressed genes; analysis of the 3741 FDR-corrected significant genes revealed significant enrichment of focal adhesion, extracellular matrix–receptor, cell adhesion, and tight junction pathways. In HCE-T cells, hyperosmotic stress increased FAK Tyr397 phosphorylation as early as 1 h without changing total FAK. At 24 h, p-FAK declined while total FAK protein levels remained stable, consistent with dephosphorylation at Tyr397; by 48 h, total FAK protein was lost, accompanied by cell injury. TJ protein abundance and junctional continuity decreased progressively with increasing osmolarity and exposure duration. PF-562271, a dual FAK/Pyk2 inhibitor, produced a concentration-dependent reduction in FAK Tyr397 phosphorylation and, at 2.5 μM, also reduced Pyk2 Tyr402 phosphorylation while partially preserving ZO-1, claudin-1, and occludin abundance. FAK knockdown independently attenuated TJ protein loss and partially preserved ZO-1 junctional continuity under 500 mOsm/L hyperosmotic stress. These findings support a time-dependent contribution of FAK-related signaling to hyperosmotic stress-induced TJ protein remodeling.
- Open Access
- 10 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6182
GutMGene-Guided Peripheral Blood Transcriptomics Identifies an FLNA-Associated Host-Gene Signal in Diabetic Retinopathy
Diabetic retinopathy (DR) reflects retinal microvascular injury and systemic immune-metabolic stress, and most public DR transcriptomic datasets lack paired microbiome/metabolomic profiles. We used gutMGene v2.0 as a curated microbe/metabolite–host gene prior and integrated it with peripheral blood transcriptomics from GSE221521. Candidate genes were refined by weighted gene co-expression network analysis (WGCNA), repeated resampling, cross-dataset assessment, mechanism scoring, peripheral blood mononuclear cell (PBMC) single-cell localization and filamin A (FLNA)-centered single-cell gene regulatory network (GRN) virtual knockout. The gutMGene prior contained 238 host genes; 15 DR-associated genes overlapped this prior, and WGCNA retained ten candidate gut microbe and microbial metabolite-related genes (GMMRGs): FLNA, AKT1, IRAK1, BCL10, CDK6, CTSD, JUP, CXCL1, CXCR2 and IL4R. Resampling prioritized FLNA as the most consistent candidate. Cross-dataset assessment localized the strongest signal to type 2 diabetes (T2D) PBMCs, retinal endothelial cells and advanced proliferative diabetic retinopathy with diabetic macular edema (PDR + DME) retinal tissue, with weaker separation in whole blood, broad retinal tissue and six-donor type 1 diabetes (T1D) PBMCs. FLNA virtual knockout predicted cell-context-dependent perturbation of immune-related transcriptional programs, including IL4R in DR B cells and CTSD in DR monocytes/NK cells. This prior-guided study identifies FLNA within a ten-gene GMMRG set as a circulating host-response signal that links curated microbe/metabolite–host records to immune-vascular and cytoskeletal remodeling in DR.
- 10 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6182
Open AccessGutMGene-Guided Peripheral Blood Transcriptomics Identifies an FLNA-Associated Host-Gene Signal in Diabetic Retinopathy
Diabetic retinopathy (DR) reflects retinal microvascular injury and systemic immune-metabolic stress, and most public DR transcriptomic datasets lack paired microbiome/metabolomic profiles. We used gutMGene v2.0 as a curated microbe/metabolite–host gene prior and integrated it with peripheral blood transcriptomics from GSE221521. Candidate genes were refined by weighted gene co-expression network analysis (WGCNA), repeated resampling, cross-dataset assessment, mechanism scoring, peripheral blood mononuclear cell (PBMC) single-cell localization and filamin A (FLNA)-centered single-cell gene regulatory network (GRN) virtual knockout. The gutMGene prior contained 238 host genes; 15 DR-associated genes overlapped this prior, and WGCNA retained ten candidate gut microbe and microbial metabolite-related genes (GMMRGs): FLNA, AKT1, IRAK1, BCL10, CDK6, CTSD, JUP, CXCL1, CXCR2 and IL4R. Resampling prioritized FLNA as the most consistent candidate. Cross-dataset assessment localized the strongest signal to type 2 diabetes (T2D) PBMCs, retinal endothelial cells and advanced proliferative diabetic retinopathy with diabetic macular edema (PDR + DME) retinal tissue, with weaker separation in whole blood, broad retinal tissue and six-donor type 1 diabetes (T1D) PBMCs. FLNA virtual knockout predicted cell-context-dependent perturbation of immune-related transcriptional programs, including IL4R in DR B cells and CTSD in DR monocytes/NK cells. This prior-guided study identifies FLNA within a ten-gene GMMRG set as a circulating host-response signal that links curated microbe/metabolite–host records to immune-vascular and cytoskeletal remodeling in DR.
- Open Access
- 1 July 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-11
Engineering strategies to enhance the research progress of mesenchymal stem cells in wound healing
Wound healing is a multifaceted biological process involving critical phases such as inflammation modulation, tissue regeneration, and angiogenesis. Traditional therapies often yield inconsistent results. Mesenchymal stem cells (MSCs)—with their abilities for self-renewal, tissue repair, angiogenesis, and immunomodulation—represent a promising avenue in regenerative medicine and wound healing. However, the efficacy of MSCs is frequently compromised by the hostile post-transplantation microenvironment. Recent advances in engineering strategies—including gene modification, preconditioning, biomaterial scaffolds, and hydrogels—have significantly enhanced the therapeutic potential of MSCs by improving their survival, proliferation, and migration. Moreover, the combined application of multiple engineering approaches further optimizes wound healing outcomes by accelerating tissue repair and reducing scar formation. In this review, we systematically summarize the mechanisms underlying MSC-mediated wound healing, their clinical applications, and the impact of various engineering strategies, with the aim of facilitating the clinical translation of engineered MSCs and providing more effective therapeutic solutions.
- 1 July 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-11
Open AccessEngineering strategies to enhance the research progress of mesenchymal stem cells in wound healing
Wound healing is a multifaceted biological process involving critical phases such as inflammation modulation, tissue regeneration, and angiogenesis. Traditional therapies often yield inconsistent results. Mesenchymal stem cells (MSCs)—with their abilities for self-renewal, tissue repair, angiogenesis, and immunomodulation—represent a promising avenue in regenerative medicine and wound healing. However, the efficacy of MSCs is frequently compromised by the hostile post-transplantation microenvironment. Recent advances in engineering strategies—including gene modification, preconditioning, biomaterial scaffolds, and hydrogels—have significantly enhanced the therapeutic potential of MSCs by improving their survival, proliferation, and migration. Moreover, the combined application of multiple engineering approaches further optimizes wound healing outcomes by accelerating tissue repair and reducing scar formation. In this review, we systematically summarize the mechanisms underlying MSC-mediated wound healing, their clinical applications, and the impact of various engineering strategies, with the aim of facilitating the clinical translation of engineered MSCs and providing more effective therapeutic solutions.
- Open Access
- 29 December 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-27
Exosomes derived from umbilical cord mesenchymal stem cells promote healing of complex perianal fistulas in rats
Complex perianal fistulas, challenging to treat and prone to recurrence, often require surgical intervention that may cause fecal incontinence and lower quality of life due to large surgical wounds and potential sphincter damage. Human umbilical cord-derived MSCs (hUC-MSCs) and their exosomes (hUCMSCs-Exo) may promote wound healing. This study assessed the efficacy, mechanisms, and safety of these exosomes in treating complex perianal fistulas in SD rats. We established a rat model, divided rats with fistulas into the control and the exosome groups. We assessed treatment efficacy through ultrasound, clinical observations, and histopathological analysis. We also evaluated the activation of the HIF-1α/TGF-β/Smad signaling pathway via PCR and Western blot and assessed serological markers for HIF-1α and inflammatory indices through ELISA. We analyzed gut microbiota and the systemic metabolic environment via untargeted metabolomics. The hUCMSCs-Exo effectively promoted healing of wound, regulated the immune balance enhanced collagen synthesis and angiogenesis in the perianal fistulas model of rats, and regulated the gut microbiota and metabolomic profiles. Results of PCR and Western blot analyses indicated that the exosomes activated HIF-1α/TGF-β/Smad signaling pathways. To the dosages tested, the 10ug/100ul concentration (medium dose) was found to be the most effective to the treatment of complex perianal fistulas. The hUCMSCs-Exo significantly promoted the healing of wound in perianal fistulas of rats and demonstrated higher safety. The underlying mechanism facilitating the healing process was likely associated with the activation of the HIF-1α/TGF-β/Smad signaling pathway.
- 29 December 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-27
Open AccessExosomes derived from umbilical cord mesenchymal stem cells promote healing of complex perianal fistulas in rats
Complex perianal fistulas, challenging to treat and prone to recurrence, often require surgical intervention that may cause fecal incontinence and lower quality of life due to large surgical wounds and potential sphincter damage. Human umbilical cord-derived MSCs (hUC-MSCs) and their exosomes (hUCMSCs-Exo) may promote wound healing. This study assessed the efficacy, mechanisms, and safety of these exosomes in treating complex perianal fistulas in SD rats. We established a rat model, divided rats with fistulas into the control and the exosome groups. We assessed treatment efficacy through ultrasound, clinical observations, and histopathological analysis. We also evaluated the activation of the HIF-1α/TGF-β/Smad signaling pathway via PCR and Western blot and assessed serological markers for HIF-1α and inflammatory indices through ELISA. We analyzed gut microbiota and the systemic metabolic environment via untargeted metabolomics. The hUCMSCs-Exo effectively promoted healing of wound, regulated the immune balance enhanced collagen synthesis and angiogenesis in the perianal fistulas model of rats, and regulated the gut microbiota and metabolomic profiles. Results of PCR and Western blot analyses indicated that the exosomes activated HIF-1α/TGF-β/Smad signaling pathways. To the dosages tested, the 10ug/100ul concentration (medium dose) was found to be the most effective to the treatment of complex perianal fistulas. The hUCMSCs-Exo significantly promoted the healing of wound in perianal fistulas of rats and demonstrated higher safety. The underlying mechanism facilitating the healing process was likely associated with the activation of the HIF-1α/TGF-β/Smad signaling pathway.
- Open Access
- 16 August 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (33) , e39350
The impact and mechanism study of Sijunzi decoction and Rg1 on proliferation and differentiation of human umbilical cord mesenchymal stem cells: An experimental study
Background: Previous researches have demonstrated that the traditional Chinese medicine could therapeutically treat inflammatory and hypoxic diseases by enhancing the functionality of mesenchymal stem cells. However, its mechanism was not yet clear. This research aimed to investigate the impact of the traditional Chinese medicine Sijunzi decoction and its herb monomer ginsenoside Rg1 on the proliferation and differentiation of human umbilical cord mesenchymal stem cells (hUC-MSCs) and explore the underlying mechanisms. Methods: Different concentrations of Sijunzi decoction and Rg1 were applied to differentiating induced hUC-MSCs. The CCK-8 test was utilized to evaluate cell proliferation activity and identify suitable drug concentrations. Alizarin Red staining was employed to detect the formation of calcium nodules, and Oil Red O staining was used to assess the formation of lipid droplets. PCR was utilized to examine gene expression related to osteogenic differentiation, adipogenic differentiation, and the HIF-1α signaling pathway in hUC-MSCs. Western blot analysis was conducted to evaluate protein expression in osteogenic differentiation and HIF-1α. ELISA was performed to measure HIF-1α signaling factors and inflammatory cytokine expression. Biochemical assays were used to assess changes in oxidative stress indicators. Results: The Sijunzi decoction and Rg1 both demonstrated a dose-dependent promotion of hUC-MSC proliferation. The Sijunzi decoction significantly increased the expression of genes and proteins relevant to osteogenesis, such as osterix, osteocalcin, RUNX2, and osteopontin, and activated the HIF-1α pathway in hUC-MSCs. (P < .05). Similar effects were observed at the gene level after treatment with Rg1. Simultaneously, Sijunzi decoction significantly reduced the secretion of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, while increasing the secretion of the anti-inflammatory cytokine IL-10 during osteogenic differentiation (P < .05). Moreover, Sijunzi decoction lowered oxidative stress levels and enhanced the antioxidant capacity of hUC-MSCs during osteogenic differentiation (P < .05). However, the impact of Sijunzi decoction on hUC-MSCs toward adipogenic differentiation was not significant (P > .05). Conclusion: Sijunzi decoction promotes the proliferation and osteogenic differentiation of hUC-MSCs, potentially through the activation of the HIF-1α signaling pathway and by modulating the microenvironment via reducing inflammation and oxidative stress levels. Rg1 might be involved in this process.
- 16 August 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (33) , e39350
Open AccessThe impact and mechanism study of Sijunzi decoction and Rg1 on proliferation and differentiation of human umbilical cord mesenchymal stem cells: An experimental study
Background: Previous researches have demonstrated that the traditional Chinese medicine could therapeutically treat inflammatory and hypoxic diseases by enhancing the functionality of mesenchymal stem cells. However, its mechanism was not yet clear. This research aimed to investigate the impact of the traditional Chinese medicine Sijunzi decoction and its herb monomer ginsenoside Rg1 on the proliferation and differentiation of human umbilical cord mesenchymal stem cells (hUC-MSCs) and explore the underlying mechanisms. Methods: Different concentrations of Sijunzi decoction and Rg1 were applied to differentiating induced hUC-MSCs. The CCK-8 test was utilized to evaluate cell proliferation activity and identify suitable drug concentrations. Alizarin Red staining was employed to detect the formation of calcium nodules, and Oil Red O staining was used to assess the formation of lipid droplets. PCR was utilized to examine gene expression related to osteogenic differentiation, adipogenic differentiation, and the HIF-1α signaling pathway in hUC-MSCs. Western blot analysis was conducted to evaluate protein expression in osteogenic differentiation and HIF-1α. ELISA was performed to measure HIF-1α signaling factors and inflammatory cytokine expression. Biochemical assays were used to assess changes in oxidative stress indicators. Results: The Sijunzi decoction and Rg1 both demonstrated a dose-dependent promotion of hUC-MSC proliferation. The Sijunzi decoction significantly increased the expression of genes and proteins relevant to osteogenesis, such as osterix, osteocalcin, RUNX2, and osteopontin, and activated the HIF-1α pathway in hUC-MSCs. (P < .05). Similar effects were observed at the gene level after treatment with Rg1. Simultaneously, Sijunzi decoction significantly reduced the secretion of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, while increasing the secretion of the anti-inflammatory cytokine IL-10 during osteogenic differentiation (P < .05). Moreover, Sijunzi decoction lowered oxidative stress levels and enhanced the antioxidant capacity of hUC-MSCs during osteogenic differentiation (P < .05). However, the impact of Sijunzi decoction on hUC-MSCs toward adipogenic differentiation was not significant (P > .05). Conclusion: Sijunzi decoction promotes the proliferation and osteogenic differentiation of hUC-MSCs, potentially through the activation of the HIF-1α signaling pathway and by modulating the microenvironment via reducing inflammation and oxidative stress levels. Rg1 might be involved in this process.